Last reviewed · How we verify

NCT05721391: Frailty

Impact of Frailty on Postoperative Complications in Oncosurgery

Completed Last updated 14 July 2023
What this trial tests

trial in Frailty in 80 participants. Completed in 12 July 2023.

Timeline
1 March 2022
Primary endpoint
30 June 2023
12 July 2023

Quick facts

Lead sponsorRajiv Gandhi Cancer Institute & Research Center, India
StatusCompleted
Study typeOBSERVATIONAL
Enrollment80
Start date1 March 2022
Primary completion30 June 2023
Estimated completion12 July 2023
Sites2 locations across India

Conditions studied

Sponsor

Rajiv Gandhi Cancer Institute & Research Center, India

Who can join

Adults 65 to 90, any sex, with Frailty or Postoperative Complications. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Advanced ageing is accompanied by loss of reserve in multiple organ systems leading to increased risk of complications after surgery.Frailty is a functional syndrome involving reduced physiological reserve and 25-56% of all elderly surgical patients are reported to be frail .

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Frailty

Currently open trials in the same condition.

Other Rajiv Gandhi Cancer Institute & Research Center, India trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05721391.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing